The worldwide AI in the medical imaging market is predicted to grow as the prevalence of chronic illnesses rises, health spending rises, AI investment rises, government spending and policy support rise, and so on. However, the market faces a number of challenges, including development limits and AI's black-box nature. Many market trends will also aid the industry's development, such as increasing variety in training datasets, detecting various ailments from a single image, and high image quality to improve algorithm performance.
The introduction of technologically advanced imaging equipmen
Facing issue in account approval? email us at info@ipt.pw
Click to Ckeck Our - FREE SEO TOOLS
The beauty and cosmetics industry is a multibillion-dollar industry that has proven to be resilient in the face of adversity. Disruptive innovations in the cosmetics sector have changed the face of the industry, forcing the industry's largest names to change their marketing strategies.
Changing consumer behavior has brought new innovations to the market such as the use of Artificial intelligence, augmented reality, personalization, digitalization and virtual reality. Machine learning, 3D printing and genomics are some other key technologies that are being utilized for product development.
T
Changing consumer behavior has brought new innovations to the market such as the use of Artificial intelligence, augmented reality, personalization, digitalization and virtual reality. Machine learning, 3D printing and genomics are some other key technologies that are being utilized for product development.
T
Cancer is one of the leading causes of death worldwide, and its prevalence is rising. As a result, in order to assess the prevalence level, healthcare practitioners concentrate on developing effective diagnostic and therapeutic options. As demand for diagnostic imaging treatments rises and public hospitals struggle to keep up with the limited number of imaging modalities at their disposal, the number of independent diagnostic centres is expanding globally.
The medical industry is leveraging the Internet of Medical Things (IoMT) to increase work effectiveness by deploying IoT-connected devices. Patients are being tracked and examined remotely by organisations and hospitals using technology.
IoMT solution firms offer software products, technology for medical devices, healthcare systems, and technical services to improve the effectiveness of solutions. These connected gadgets help gather, generate, analyse, and transmit data to a centralised system for further processing.
IoMT solution firms offer software products, technology for medical devices, healthcare systems, and technical services to improve the effectiveness of solutions. These connected gadgets help gather, generate, analyse, and transmit data to a centralised system for further processing.
Cancer vaccines development has been intensively pursued over the past half decade with moderate success. However, recent advancements in the fields of molecular biology, genetics, biochemistry, and immunology have renewed interest and allowed the development of promising cancer vaccine candidates.
Major factors driving the cancer vaccine market growth include the increasing number of cancer cases, rising investments and funding by government organizations for developing cancer vaccines, and technological developments in cancer vaccines platforms.
Major factors driving the cancer vaccine market growth include the increasing number of cancer cases, rising investments and funding by government organizations for developing cancer vaccines, and technological developments in cancer vaccines platforms.
Ingenious e-Brain Solutions forecasts a considerable trend for “AI democratization” where various machine learning/deep learning technologies become available in pre-trained, pre-configured “off-the-shelf” formats, or relatively ready-to-use formats — via cloud-based models, frameworks, and drag-and-drop AI-pipeline building platforms (for example, KNIME). Companies such as Google, Tencent, Nvidia, Microsoft, and others are expanding into the healthcare space by not only providing specialized services and tools to pharma counterparties but also investing directly in biotech start-ups and large